These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
125 related articles for article (PubMed ID: 1149303)
41. Growth hormone response to propranolol and L--dopa in obese subjects. Barbarine A; De Marinis L; Troncone L Metabolism; 1978 Mar; 27(3):275-8. PubMed ID: 628352 [TBL] [Abstract][Full Text] [Related]
42. Effect of cyproheptadine on the spontaneous diurnal variations of plasma ACTH-cortisol and ACTH-GH secretion induced by l-dopa. Delitala G; Masala A; Alagna S; Devilla L Biomedicine; 1975 Dec; 23(10):406-9. PubMed ID: 177112 [TBL] [Abstract][Full Text] [Related]
43. Differential effects of dopamine agonists and haloperidol on release of prolactin, thyroid stimulating hormone, growth hormone and luteinizing hormone in rats. Mueller GP; Simpkins J; Meites J; Moore KE Neuroendocrinology; 1976; 20(2):121-35. PubMed ID: 958594 [TBL] [Abstract][Full Text] [Related]
44. Effect of glucose on the glucagon response to L-dopa in normal and diabetic subjects. Klimes I; Vigas M; Jurcovicová J; Repceková D; Kolesár P Diabetes; 1978 Apr; 27(4):396-9. PubMed ID: 640244 [TBL] [Abstract][Full Text] [Related]
53. Modification of the actions of some neuroactive drugs by growth hormone. Tang LC; Cotzias GC Arch Neurol; 1976 Feb; 33(2):131-4. PubMed ID: 1252146 [TBL] [Abstract][Full Text] [Related]
54. Reduced growth hormone response to L-dopa and pyridostigmine in obesity. Lee EJ; Kim KR; Lee KM; Lim SK; Lee HC; Lee JH; Lee DJ; Huh KB Int J Obes Relat Metab Disord; 1994 Jul; 18(7):465-8. PubMed ID: 7920871 [TBL] [Abstract][Full Text] [Related]
55. Combined oral L-dopa and propranolol for growth hormone provocation. Blackett PR; Altmiller DH; Seely JR; Cagas CR South Med J; 1979 Jul; 72(7):842-4. PubMed ID: 451694 [TBL] [Abstract][Full Text] [Related]
56. Evidence for dopaminergic stimulation of growth velocity in some hypopituitary children. Huseman CA; Hassing JM J Clin Endocrinol Metab; 1984 Mar; 58(3):419-25. PubMed ID: 6420440 [TBL] [Abstract][Full Text] [Related]
57. [Normalization of the GH response to L-DOPA in acromegalics after treatment with bromocriptine]. Carmina E; Lanzara P; Lo Coco R; Longo RA; Jannì A Arch Sci Med (Torino); 1979; 136(3):421-5. PubMed ID: 549547 [TBL] [Abstract][Full Text] [Related]
58. Effect of melatonin on L-tryptophan- and apomorphine-stimulated growth hormone secretion in man. Koulu M; Lammintausta R J Clin Endocrinol Metab; 1979 Jul; 49(1):70-2. PubMed ID: 447817 [TBL] [Abstract][Full Text] [Related]
59. Sensitization and tolerance to apomorphine in men: yawning, growth hormone, nausea, and hyperthermia. Szechtman H; Cleghorn JM; Brown GM; Kaplan RD; Franco S; Rosenthal K Psychiatry Res; 1988 Mar; 23(3):245-55. PubMed ID: 3387500 [TBL] [Abstract][Full Text] [Related]
60. L-dopa is a potent stimulator of cortisol in short children. Marakaki C; Papadimitriou DT; Papadopoulou A; Fretzayas A; Papadimitriou A Horm Res Paediatr; 2014; 81(6):386-90. PubMed ID: 24802138 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]